# Post x_1016368503723577300 - Post ID: `x_1016368503723577300` - Platform: X (Twitter) - Posted: 2018-07-09T21:08:29.000Z (UTC) - Deleted: no - Repost: no - Canonical URL: https://trump.fm/post/x_1016368503723577300 - Analysis page: https://trump.fm/post/x_1016368503723577300/analysis - Audio narration: https://static.trump.fm/audio/x_1016368503723577300.mp3 (a synthesized voice reading the post text, not a recording) ## Post text > Pfizer &, others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor &, others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe &, elsewhere. We will respond! ## Engagement - Likes: 0 - Reposts: 22,936 - Replies: 0 - Views: unknown - Metrics collected: 2026-02-01T01:33:25.040Z (UTC) # Analysis _Machine-generated by trump.fm on 2026-03-15T06:08:27.462Z (UTC): a model's reading of this post, not his words. Its psychological terms describe the language, not a clinical assessment of him._ ## Summary July 9, 2018 pharmaceutical attack post shows Trump operating in supply-seeking grandiose mode, performing the populist protector role against a convenient corporate villain. Posted at 5:08 PM EDT on an extraordinarily busy day (Kavanaugh announcement at 9 PM), timing suggests possible aide scheduling. Rhetorical fingerprints — 'bargain basement prices,' shame-based moral attack, vague sovereign threat — are authentically Trump-inflected, yielding a mixed authorship verdict. The post deploys standard populist architecture: name target, attribute malicious motivation, invoke helpless victims, invoke international exploitation comparison, close with ambiguous power projection. 'We will respond!' is characteristically unspecific, preserving maximum optionality while performing strength. Cognitively unremarkable — normal complexity and coherence for the period, no deviation from 2018 baseline. Shadow projection is the clinically notable element: Trump attributes exploitative behavior toward the vulnerable ('taking advantage of the poor') to Pfizer, a trait documented in Trump's own business history (Trump University, Atlantic City creditors). Factually, the underlying premise is substantially accurate — Pfizer did raise prices in July 2018 and subsequently halted increases under political pressure — though 'for no reason' oversimplifies pharmaceutical economics. Danger level: none. No dehumanizing language, no violent imagery, no individual target identified. This post represents maintenance-mode populist engagement rather than a psychologically acute moment. ## Post Analysis: Pfizer Drug Pricing Attack — July 9, 2018 ### Authorship Attribution Posted at **21:08:29 UTC = 5:08 PM EDT** on July 9, 2018. Trump was almost certainly in Washington, D.C. — the Kavanaugh Supreme Court announcement was scheduled for 9 PM that same evening, requiring him to be at the White House. **5:08 PM EDT is solidly within business hours**, which is a modest indicator against spontaneous Trump authorship. However, the rhetorical fingerprints complicate this: the colloquial idiom "bargain basement prices," the shame-based opening gambit, the invocation of "the poor & others unable to defend themselves," and the punchy ambiguous close ("We will respond!") are all consistent with Trump's authentic voice and documented stylistic patterns. The sentence length and complexity are within normal Trump range — not notably polished. Assessment: likely a hybrid — aide-assisted or scheduled, but dictated from Trump's actual talking points rather than staff-generated content. The idiom density and moral-accusatory structure are too Trump-specific to be pure staff work. **Medium confidence, leaning slightly aide-drafted in Trump's voice (0.55 on Trump-authored scale).** --- ### Level 1: Dispositional Traits (Big Five) - **Extraversion (high):** Assertive, dominant, public-facing attack posture. Announces future action without hesitation. - **Agreeableness (very low):** Confrontational framing toward a powerful institution; zero modesty or diplomatic hedging. - **Conscientiousness (moderate):** Achievement-striving evident ("We will respond!"), but deliberation is minimal — no policy specifics offered. - **Neuroticism (mild):** Moral indignation present but controlled; no ALL CAPS, no expletive substitutes. Less dysregulated than baseline rage posts. - **Openness (low):** Binary moral framing — corporations are exploiters, the poor are victims. No acknowledgment of complexity (R&D costs, regulatory factors). --- ### Level 2: Characteristic Adaptations (Motives and Schemas) **Dominant motive: Agency/Power** operating through a **Populist Protector schema.** The cognitive architecture here is not defensive (no injury to repair) but *performative*: Trump positions himself as sovereign champion of the vulnerable against a powerful, named, shamed villain. "The poor & others unable to defend themselves" is not a policy category but a rhetorical object — their helplessness amplifies his projected strength. **Supply-seeking trigger:** This is fundamentally a validation-harvesting post. Pharmaceutical companies are among the most disliked institutions in American public opinion; attacking them generates populist approval at minimal political cost. No narcissistic injury is discernible as a proximate trigger. This is *maintenance-mode* supply-seeking dressed in moral indignation. The international comparison ("bargain basement prices to other countries in Europe & elsewhere") activates a well-worn grievance schema: America is exploited by foreigners and by domestic elites simultaneously. This dual-exploitation narrative is a characteristic Trump adaptation that efficiently consolidates two distinct audience grievances in a single frame. --- ### Level 3: Narrative Identity - **Protagonist role:** Protector/Warrior — the one who names the threat and promises retribution. - **Contrasting other:** Pfizer (and unnamed "others") — faceless corporate power exploiting the vulnerable. - **Narrative sequence:** Contamination adjacent — a good society (fair drug pricing) corrupted by corporate greed. Trump's vow to "respond" sets up a prospective redemption arc. - **Identity claims:** Implicitly: *I see what others ignore. I speak for those who cannot defend themselves. I act where others defer.* The phrase "We will respond" is rhetorically precise in its vagueness: it projects presidential authority ("We" = the executive branch), promises consequences without specifying them, and creates a future accountability frame that can be retroactively satisfied by almost any pharmaceutical-adjacent action. --- ### Level 4: Clinical Indicators **Narcissistic dynamics:** Mild to moderate. This post is more *supply-seeking* than *rage-driven*. The grandiose register is present but subdued — Trump is casting himself as protector rather than humiliating a personal enemy. No ego-syntonic sadism is evident. **Narcissistic state:** Grandiose (expansive, dominant), not vulnerable. No victimhood framing. **Defense mechanisms:** - **Splitting (immature):** Corporations = pure exploiters; the poor = pure victims. No acknowledgment of market complexity. - **Rationalization (neurotic):** "for no reason" papers over the genuine complexity of pharmaceutical pricing; simplification serves the moral narrative. - **Acting out (immature):** Public shaming via social media as direct expression of punitive impulse, bypassing regulatory/legislative process. **Malignant narcissism sub-scores:** Low activation in this post. Narcissistic features moderate, antisocial features low, paranoid features low (no persecution framing), sadism low. --- ### Cognitive Status Post shows **normal complexity** for the 2018 period baseline. Sentence structure is coherent, logical progression (claim → evidence → threat) is intact, vocabulary appropriate. No word-finding difficulty, perseveration, temporal confusion, or name errors. The "&," display artifact is a data encoding issue, not a language production error. **Baseline deviation: None.** No flag warranted. --- ### Rhetorical Analysis **Techniques deployed:** 1. **Ad hominem moralism:** "should be ashamed" — bypasses policy argument by attacking character/ethics. 2. **Appeal to pity/protection:** "the poor & others unable to defend themselves" activates moral-emotional response. 3. **International comparison as grievance:** European prices framed not as a policy model to emulate but as evidence of American exploitation. 4. **Vague threat (power projection):** "We will respond!" — all threat, zero commitment. Preserves optionality while performing strength. 5. **Name-and-shame:** Specifically naming Pfizer activates news coverage and corporate anxiety at no policy cost. 6. **False simplification:** "for no reason" delegitimizes the opposing explanation without engaging it. **Dehumanizing language:** Absent. Corporations are shamed but not dehumanized. **Violent imagery:** Absent. --- ### Gaslighting & Reality Distortion Minimal. The underlying factual substrate (US drug prices higher than European, Pfizer did raise prices in July 2018) is largely accurate. "For no reason" is an oversimplification but not a documented falsehood. No DARVO structure, no denial of documented events, no epistemic manipulation of followers' perceptions. --- ### Fact Verification | Claim | Verdict | Evidence | |-------|---------|----------| | "Pfizer raised drug prices" | **True** | Pfizer announced price increases effective July 1, 2018 on approximately 100 drugs. The company subsequently announced a temporary halt to increases following political pressure, including this post. | | "Raised prices for no reason" | **Mostly False** | Pharmaceutical companies cite R&D costs, patent economics, PBM/insurer negotiations, and market dynamics as reasons for pricing decisions. These explanations are contested and arguably self-serving, but 'no reason' is a categorical oversimplification. | | "Giving bargain basement prices to other countries in Europe & elsewhere" | **Mostly True** | Reference pricing, centralized government negotiation, and regulatory frameworks in European countries do produce substantially lower prices for identical branded drugs. 'Bargain basement' is hyperbolic but the directional claim is well-supported. | | "Taking advantage of the poor and others unable to defend themselves" | **Unverifiable** | The differential pricing pattern between insured and uninsured/underinsured patients is real and documented. Intent attribution ('taking advantage') is non-falsifiable as stated. | Overall Veracity: 63% ## Authorship Analysis **Uncertain** (score: 55%) ### Indicators - 5:08 PM EDT — business hours, atypical for spontaneous authentic Trump - Announced Kavanaugh nomination same evening, White House likely coordinating media - Colloquial idiom 'bargain basement prices' consistent with authentic Trump vocabulary - 'We will respond!' closing — vague threat pattern highly characteristic of Trump - Shame-based moral attack without policy specifics — Trump stylistic signature ## Psychological Profile ### State **Grandiose State** **Trigger:** Supply Seeking (pharmaceutical industry price increases) Sentiment: -0.45 ### Clinical **Malignant Narcissism:** - Narcissistic: 40% - Antisocial: 15% - Paranoid: 10% - Sadism: 10% **Defense Mechanisms:** - splitting (immature) - rationalization (neurotic) - acting out (immature) **Cognitive Complexity:** - Complexity: 48% **Parasocial Techniques:** - Populist identification ('the poor & others unable to defend themselves') - Shared grievance activation (pharmaceutical pricing as common enemy) - Protective authority performance ('We will respond!') ## Fact Checks (4) _The model's verdicts from 2026-03-15._ > Pfizer raised drug prices **TRUE** Pfizer announced price increases effective July 1, 2018 on approximately 100 drugs. The company subsequently announced a temporary halt to increases following political pressure, including this post. Sources: General knowledge — Pfizer July 2018 price increase announcement and subsequent reversal is well-documented in the period > Raised prices for no reason **MOSTLY FALSE** Pharmaceutical companies cite R&D costs, patent economics, PBM/insurer negotiations, and market dynamics as reasons for pricing decisions. These explanations are contested and arguably self-serving, but 'no reason' is a categorical oversimplification. Sources: Pharmaceutical industry pricing literature, general knowledge > Giving bargain basement prices to other countries in Europe & elsewhere **MOSTLY TRUE** Reference pricing, centralized government negotiation, and regulatory frameworks in European countries do produce substantially lower prices for identical branded drugs. 'Bargain basement' is hyperbolic but the directional claim is well-supported. Sources: Comparative pharmaceutical pricing studies, general knowledge of international drug pricing mechanisms > Taking advantage of the poor and others unable to defend themselves **UNVERIFIABLE** The differential pricing pattern between insured and uninsured/underinsured patients is real and documented. Intent attribution ('taking advantage') is non-falsifiable as stated. Sources: General knowledge of US pharmaceutical access and pricing disparities Overall Veracity: 63% ## Tags - populist_attack (85%) - corporate_villain_construction (80%) - supply_seeking (75%) - protector_narrative (80%) - shadow_projection (60%) - pharmaceutical_pricing (90%) - aide_assisted_possible (55%) - vague_threat (70%) - international_grievance (65%) ## That day _From trump.fm's machine-generated digest of the day, not his words._ **Pre-Summit Posturing: A Day of Exploitation Grievances and Controlled Grandiosity Before Kavanaugh and NATO** Trump spent July 9 juggling multiple policy fronts from Washington -- hammering NATO allies over defense spending ahead of a Brussels summit, teasing his Supreme Court pick, and lashing out at Pfizer and the New York Times. The dominant mood was confident and combative, anchored by a running theme that everyone -- European allies, pharmaceutical companies, trade partners -- is taking advantage of America. A brief defensive moment came when he pushed back against a Times report on a breastfeeding resolution, but he quickly returned to his preferred offensive posture. The evening belonged to the Kavanaugh nomination announcement, which he had been building anticipation for all day. Full digest for 2018-07-09: https://trump.fm/date/2018-07-09/analysis ## Citation - APA: Trump, D. J. (2018, July 9). Pfizer &, others should be ashamed that they... [Social media post]. X (Twitter). trump.fm. https://trump.fm/post/x_1016368503723577300 - MLA: Trump, Donald J. "Pfizer &, others should be ashamed that they have raised..." X (Twitter), 9 Jul. 2018. trump.fm, https://trump.fm/post/x_1016368503723577300. Accessed 9 Oct. 2026. - Chicago: Donald J. Trump, "Pfizer &, others should be ashamed that they have raised...," X (Twitter), July 9, 2018, archived at trump.fm, https://trump.fm/post/x_1016368503723577300. ## For agents - Site overview: https://trump.fm/llms.txt - API specification: https://trump.fm/openapi.json - MCP server: https://trump.fm/mcp (search and fetch tools, no auth) - This post as JSON: https://trump.fm/api/posts/x_1016368503723577300 - Analysis as JSON: https://trump.fm/api/analysis/x_1016368503723577300 - All citation formats: https://trump.fm/api/cite/x_1016368503723577300 - Same day: https://trump.fm/date/2018-07-09 - The record alone, without the analysis: https://trump.fm/post/x_1016368503723577300.md?analysis=false _Markdown view of a trump.fm page. Post, analysis, date, feed, contradictions, search and about pages answer in markdown at their URL with `.md` appended (`/index.md` for the home page), or when sent `Accept: text/markdown`._